Vision Training for Age-Related Macular Degeneration
(FLAP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to assist individuals with age-related macular degeneration, a condition that causes vision loss. It examines whether eye training can improve vision by testing two methods: one focuses on visual sensitivity (Training visual sensitivity), and the other combines various visual tasks (Combination training). Individuals diagnosed with macular degeneration, who have severely impaired vision in both eyes and have experienced these issues for at least two years, might be suitable candidates. The research aims to discover treatments that could benefit millions facing vision loss. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that may lead to new treatments for vision loss.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this vision training is safe for individuals with age-related macular degeneration?
Research has shown that training the eyes to see better can aid individuals with age-related macular degeneration (AMD). Some studies have found that vision can improve through exercises that enhance the ability to notice details more clearly. This training is generally safe, as it relies on exercises rather than drugs or surgery.
For training that combines various exercises, specific safety information remains less clear. However, since it involves exercises and not medication, it is likely low-risk. These methods are non-invasive, meaning they don't involve surgery or drugs, which typically results in fewer side effects.12345Why are researchers excited about this trial?
Researchers are excited about the Vision Training for Age-Related Macular Degeneration because it offers a unique approach compared to traditional treatments like anti-VEGF injections. Unlike these standard therapies that mainly focus on slowing disease progression by targeting blood vessel growth, this trial explores perceptual learning techniques to enhance visual processing. The "Training visual sensitivity" arm specifically aims to improve how the brain processes visual information, potentially enhancing visual acuity through exercises with Gabor patches. Meanwhile, the "Combination training" arm combines visual sensitivity training with spatial integration tasks, potentially offering synergistic benefits that surpass the effects of either method alone. This innovative focus on retraining the brain's visual processing is what makes these treatments stand out.
What evidence suggests that this trial's treatments could be effective for age-related macular degeneration?
Research has shown that training to enhance visual acuity can benefit individuals with age-related macular degeneration (AMD). Studies have found that this training can clarify and sharpen vision, assisting with everyday tasks and making daily activities easier for those with low vision. In this trial, participants will join different treatment arms. One arm will focus on training visual sensitivity, which has shown promise in improving acuity. Another arm will explore combination training, where researchers are investigating whether combining different training methods proves more effective than using just one. Although the effectiveness of this combination is still under study, early results suggest it might improve overall vision.678910
Are You a Good Fit for This Trial?
This trial is for adults aged 18-89 with severe vision impairment (20/100 or worse) due to Macular Degeneration, confirmed by an ophthalmologist. Participants must have had this condition for at least two years and live within 50 miles of the study site. Those with certain body measurements, metal implants, claustrophobia, hearing impairments, significant head injuries, mental health conditions like hallucinations/delusions, or specific tattoos near the head cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo perceptual learning training focusing on visual sensitivity, spatial integration, and attention and eye-movements.
Follow-up
Participants are monitored for changes in visual processing and brain plasticity after training completion.
What Are the Treatments Tested in This Trial?
Interventions
- Combination training
- Training visual sensitivity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of California, Riverside
Collaborator